Javascript must be enabled to continue!
Abstract B13: Arizona cancer research network analysis: Discovery to delivery
View through CrossRef
Abstract
Background: Networks are frequently viewed as important for moving innovation beyond the boundaries of individual organizations, especially for enhancing translational research. This study used social network analysis to discover the extent and nature of involvement in collaborative relationships among the key organizations participating in cancer research activities in Arizona.
Methods: Data were collected in 2007 from 18 of 21 organizations involved in research in the Arizona Cancer Coalition, including academic institutions, private research institutes, and organizations dedicated to healthcare delivery, public health and support/advocacy. Key informants in each organization reported their collaborative relationships with every other organization in the Coalition for each of three types of cancer research activities, discovery, development, and delivery (3D). Data were analyzed using network analytic software (UCInet). Network measures included two global ‘whole network’ measures (network centralization and density) and one organizational level measure (degree centrality).
Results: The results of the network analysis showed the most highly connected, or dense, network ties were found when cancer research focused on delivery, closely followed by discovery. Organizational centrality in the development network is highly and positively correlated with both centrality in the discovery (r=.71, p<.001) and the delivery networks (r=.77, p<.001). In contrast, the relationship between centrality in the discovery and delivery network is quite weak (r=.33, not significant).These findings are consistent with the fact that discovery and delivery are at opposite ends of the research continuum, and thus, the central actors in each network are less likely to overlap. In addition, the importance of cancer research to an organization's mission is strong and positive, but only for the discovery (r=.61, p≤.01) and development (r=.51, p≤.05) networks
Conclusions: The research demonstrated how network analysis can be used to understand the extent to which organizations involved in cancer research are able to collaborate both within and across the 3D continuum. Findings suggested substantial differences in network involvement, depending on the type of research being conducted, while also demonstrating the key role played by a comprehensive cancer center in connecting organizations that might be involved in very different aspects of the research process.
Citation Information: Cancer Prev Res 2010;3(1 Suppl):B13.
American Association for Cancer Research (AACR)
Title: Abstract B13: Arizona cancer research network analysis: Discovery to delivery
Description:
Abstract
Background: Networks are frequently viewed as important for moving innovation beyond the boundaries of individual organizations, especially for enhancing translational research.
This study used social network analysis to discover the extent and nature of involvement in collaborative relationships among the key organizations participating in cancer research activities in Arizona.
Methods: Data were collected in 2007 from 18 of 21 organizations involved in research in the Arizona Cancer Coalition, including academic institutions, private research institutes, and organizations dedicated to healthcare delivery, public health and support/advocacy.
Key informants in each organization reported their collaborative relationships with every other organization in the Coalition for each of three types of cancer research activities, discovery, development, and delivery (3D).
Data were analyzed using network analytic software (UCInet).
Network measures included two global ‘whole network’ measures (network centralization and density) and one organizational level measure (degree centrality).
Results: The results of the network analysis showed the most highly connected, or dense, network ties were found when cancer research focused on delivery, closely followed by discovery.
Organizational centrality in the development network is highly and positively correlated with both centrality in the discovery (r=.
71, p<.
001) and the delivery networks (r=.
77, p<.
001).
In contrast, the relationship between centrality in the discovery and delivery network is quite weak (r=.
33, not significant).
These findings are consistent with the fact that discovery and delivery are at opposite ends of the research continuum, and thus, the central actors in each network are less likely to overlap.
In addition, the importance of cancer research to an organization's mission is strong and positive, but only for the discovery (r=.
61, p≤.
01) and development (r=.
51, p≤.
05) networks
Conclusions: The research demonstrated how network analysis can be used to understand the extent to which organizations involved in cancer research are able to collaborate both within and across the 3D continuum.
Findings suggested substantial differences in network involvement, depending on the type of research being conducted, while also demonstrating the key role played by a comprehensive cancer center in connecting organizations that might be involved in very different aspects of the research process.
Citation Information: Cancer Prev Res 2010;3(1 Suppl):B13.
Related Results
Serpin B13 Plays a Role in Beta-Cell Development and Progression to Insulin-Dependent Diabetes
Serpin B13 Plays a Role in Beta-Cell Development and Progression to Insulin-Dependent Diabetes
Identifying natural factors of the progression to type 1 diabetes (T1D) provides a unique opportunity to develop novel preventative strategies for this disease. Our laboratory has ...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose:
To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract
Background: Prostate cancer is the second most frequent malignancy (after lung cancer) in men worldwide. It is the third most common cancer in men in Algeri...
Detection of gene communities in multi-networks reveals cancer drivers
Detection of gene communities in multi-networks reveals cancer drivers
In the past years the advent of high-throughput experimental technologies provided biologists with a flood of molecular data. This huge amount of information requires the design of...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract
Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...

